Transcatheter Tricuspid Valve Replacement in a Heart Transplant Recipient

Chloe Kharsa1, Isadora Sande Mathias1, Hassaan Bin Arshad1

  • 1Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.

JACC. Case Reports
|December 11, 2025
PubMed
Summary

Transcatheter tricuspid valve replacement (TTVR) using the EVOQUE valve is feasible and safe for heart transplant recipients with severe tricuspid regurgitation (TR). This innovative therapy offers a new option for high-risk patients with limited treatment choices.